Conseco Boosts Quarterly Cash Dividend.CARMEL, Ind IND Investigational new drug Therapeutics A status assigned by the FDA to a drug before allowing its use in humans, exempting it from premarketing approval requirements so that experimental clinical trials may be conducted. See Phase 1.2, 3 studies, Sponsorship. .--(BUSINESS WIRE)--July 29, 1999-- The board of directors of Conseco, Inc. (NYSE NYSE See: New York Stock Exchange :CNC (Computerized Numerical Control) See numerical control. CNC - Collaborative Networked Communication ) increased the regular quarterly cash dividend on the company's common stock by 7 percent, to 15 cents per share Cents per share The amount of a mutual fund's dividend or capital gains distributions that a shareholder will receive for each share owned. from 14 cents per share, effective with the next dividend payment on Oct. 1, 1999. Shareholders of record on Sept. 20, 1999, will be entitled en·ti·tle tr.v. en·ti·tled, en·ti·tling, en·ti·tles 1. To give a name or title to. 2. To furnish with a right or claim to something: to the October 1 dividend. Chairman Stephen C. Hilbert said, "Conseco remains committed to building shareholder value primarily by reinvesting our earnings for future growth. Nevertheless, the board decided that an increase in the dividend was appropriate in order to reflect Conseco's increased profitability. The board intends to annually assess the adequacy of the dividend yield." Headquartered in Carmel, Ind., Conseco is one of middle America's leading sources for insurance, investment and lending products. Through its subsidiaries and a nationwide network of insurance agents and finance dealers, Conseco provides solutions for both wealth protection and wealth creation to 12 million customers. World Wide Web http://www.conseco.com Investor Hotline 800.4.CONSECO Fax-on-Demand 800.344.6452 |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion